Skip to main content

Living Donor Evaluation and Selection

  • Reference work entry
  • First Online:
Contemporary Kidney Transplantation

Part of the book series: Organ and Tissue Transplantation ((OTT))

  • 954 Accesses

Abstract

Living donors are frequently used for kidney transplantation in the United States. This option offers a superior patient and graft survival over deceased donor transplantation. It is also an excellent solution to close the widening gap between patients awaiting renal transplantation and number of transplants done. Organ Procurement and Transplantation Network (OPTN) has specified the minimum general and kidney-specific requirements for suitability as a living kidney donor. Transplant programs across the United States have specific medical criteria for living donation which may be beyond the minimum specified by OPTN. Although living kidney donation is deemed safe, a thorough evaluation to assess medical suitability, infectious and malignancy transmission risk, and assessment of residual organ reserve in the donor is required. This chapter covers all aspects of medical evaluation of the living kidney donor in detail. In general, most programs are now more willing to accept donors with treated hypertension, obesity, or a history of kidney stones provided that certain conditions are met. Such aspects of medically complex living kidney donors are also presented here. Certain recipient conditions that should prompt genetic testing in related living donor candidates are also discussed. Other OPTN requirements such as psychosocial evaluation of living donors and their follow-up by the donor center are also highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

AER:

Albumin excretion rate

AUA:

American Urologic Association

BMI:

Body mass index

CMS:

Centers for Medicare and Medicaid Services

DTAC:

Disease Transmission and Advisory Committee

ESRD:

End-stage renal disease

KDIGO:

Kidney Disease Improving Global Outcomes

NAT:

Nucleic acid test

OPTN:

Organ procurement and transplantation network

PHS:

Public Health Service

SRTR:

Scientific Registry of Transplant Recipients

TBMN:

Thin basement membrane nephropathy

UNOS:

United Network for Organ Sharing

WHO:

World Health Organization

References

  • Audrezet MP, Cornec-Le Gall E, Chen JM et al (2012) Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33:1239–1250

    Article  CAS  PubMed  Google Scholar 

  • Boudville N, Prasad GV, Knoll G et al (2006) Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 145:185–196

    Article  PubMed  Google Scholar 

  • Bu FX, Maga T, Meyer NC, Wang K, Thomas CP et al (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25:55–64

    Article  CAS  PubMed  Google Scholar 

  • Buell JF, Beebe TM, Trofe J et al (2004) Donor transmitted malignancies. Ann Transplant 9:53–56

    PubMed  Google Scholar 

  • Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252

    Article  CAS  PubMed  Google Scholar 

  • Cohen RA, Brown RS (2003) Clinical practice. Microscopic hematuria. N Engl J Med 348:2330–2338

    Article  PubMed  Google Scholar 

  • Davis R, Jones JS, Barocas DA et al (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188:2473–2481

    Article  PubMed  Google Scholar 

  • Doshi MD, Goggins MO, Li L et al (2013) Medical outcomes in African American live kidney donors: a matched cohort study. Am J Transplant 13:111–118

    Article  CAS  PubMed  Google Scholar 

  • Glodny B, Unterholzner V, Taferner B et al (2009) Normal kidney size and its influencing factors – a 64-slice MDCT study of 1.040 asymptomatic patients. BMC Urol 9:19

    Article  PubMed  PubMed Central  Google Scholar 

  • Gracida C, Espinoza R, Cedillo U et al (2003) Kidney transplantation with living donors: nine years of follow-up of 628 living donors. Transplant Proc 35: 946–947

    Article  CAS  PubMed  Google Scholar 

  • Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX (2016) Chronic kidney disease prognosis consortium. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374(5): 411–421

    Article  CAS  PubMed  Google Scholar 

  • Hart TC, Gorry MC, Hart PS et al (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882–892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD (2005) Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 5:1057–1064

    Article  PubMed  Google Scholar 

  • HIV transmitted from a living organ donor-New York City, 2009. Am J Transplant 2011; 11:1334–1337

    Google Scholar 

  • Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski JP, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, Knoll G, Segev D, Brubaker S, Hasz R, Lebovitz DJ, Mulligan D, O’Connor K, Pruett T, Mozes M, Lee I, Delmonico F, Fischer S (2010) Nucleic acid testing (NAT) of organ donors: is the “best” test the right test? A consensus conference report. Am J Transplant 10:889–899

    Article  CAS  PubMed  Google Scholar 

  • Ibrahim HN, Foley R, Tan L et al (2009) Long-term consequences of kidney donation. N Engl J Med 360:459–469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jais JP, Knebelmann B, Giatras I et al (2003) X-linked Alport syndrome: natural history and genotype phenotype correlations in girls and women belonging to 195 families: a “European community Alport syndrome concerted action” study. J Am Soc Nephrol 14: 2603–2610

    Article  PubMed  Google Scholar 

  • kidney disease improving global outcomes practice guideline on the evaluation and follow-up care of living kidney donors draft document pdf. Nov 2015

    Google Scholar 

  • Kirby A, Gnirke A, Jaffe DB et al (2013) Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet 45:299–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuppachi S, Smith RJH, Thomas CP (2015) Evaluation of genetic renal diseases in potential living kidney donors. Curr Transpl Rep 2:1–14

    Article  Google Scholar 

  • Lentine KL, Lam NN, Axelrod D, Schnitzler MA, Garg AX, Xiao H, Dzebisashvili N, Schold JD, Brennan DC, Randall H, King EA, Segev DL (2016) Perioperative complications after living kidney donation: a National Study. Am J Transplant 16(6): 1848–1857

    Article  CAS  PubMed  Google Scholar 

  • Levin A, Lamb EJ, White CT et al (2013) Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150

    Article  Google Scholar 

  • Mandelbrot DA, Pavlakis M, Danovitch GM et al (2007) The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant 7: 2333–2343

    Article  CAS  PubMed  Google Scholar 

  • Mjoen G, Hallan S, Hartmann A et al (2014) Long-term risks for kidney donors. Kidney Int 86:162–167

    Article  PubMed  Google Scholar 

  • Nalesnik MA, Woodle ES, DiMaio JM, Vasudev B, Teperman LW, Covington S, Taranto S, Gockerman JP, Shapiro R, Sharma V, Swinnen LJ, Yoshida A, Ison MG (2011) Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant 11:1140–1147

    Article  CAS  PubMed  Google Scholar 

  • Nordén G, Lennerling A, Nyberg G (2000) Low absolute glomerular filtration rate in the living kidney donor: a risk factor for graft loss. Transplantation 70(9): 1360–1362

    Article  PubMed  Google Scholar 

  • OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing). OPTN policies, policy 14: living donation. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN_Policies.pdf. Accessed on 10 July 2016

  • OPTN/UNOS (2014) Recognizing seasonal and geographically endemic infections in organ donors: considerations during living donor evaluation. http://optn.transplant.hrsa.gov/media/1138/seasonal_disease_guidance.pdf. Accessed on 24 June 2016

  • Parsa A, Kao WH, Xie D et al (2013) APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369:2183–2196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pascual J, Abramowicz D, Cochat P et al (2014) European renal best practice guideline on the management and evaluation of the kidney donor and recipient. Nefrologia 34:293–301

    PubMed  Google Scholar 

  • Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R et al (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205–212

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM et al (2014) Imaging-based diagnosis of autosomal dominant polycystic kidney disease. J Am Soc Nephrol 26: 746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61:274–278

    Article  CAS  PubMed  Google Scholar 

  • Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M et al (2011) The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11:1025–1030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM et al (2007) Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18:2143–2160

    Article  CAS  PubMed  Google Scholar 

  • Savige J, Gregory M, Gross O et al (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364–375

    Article  CAS  PubMed  Google Scholar 

  • Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America project. Prevalence of kidney stones in the United States. Eur Urol 62(1): 160–165

    Article  PubMed  PubMed Central  Google Scholar 

  • Seem DL, Lee I, Umscheid CA et al (2013) Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation. Am J Transplant 13:1953–1962

    Article  CAS  PubMed  Google Scholar 

  • Segev DL, Muzaale AD, Caffo BS et al (2010) Perioperative mortality and long-term survival following live kidney donation. JAMA 303:959–966

    Article  CAS  PubMed  Google Scholar 

  • Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR (1982) Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 97(4):516

    Article  CAS  PubMed  Google Scholar 

  • Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817

    Article  PubMed  Google Scholar 

  • Sutton JM (1990) Evaluation of hematuria in adults. JAMA 263:2475–2480

    Article  CAS  PubMed  Google Scholar 

  • The British Transplant Society and The Renal Association (2011) The United Kingdom Guidelines for Living Donor Kidney Transplantation, 3rd edn. https://www.bts.org.uk/Documents/Guidelines/Active/UK%20Guidelines%20for%20Living%20Donor %20Kidney%20July%202011.pdf. Accessed 24 June 2016

  • Thomas CP, Erlandson JC, Edghill EL, Hattersley AT, Stolpen AH (2008) A genetic syndrome of chronic renal failure with multiple renal cysts and early onset diabetes. Kidney Int 74:1094–1099

    Article  CAS  PubMed  Google Scholar 

  • Vivante A, Afek A, Frenkel-Nir Y et al (2011) Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 306:729–736

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Vrtiska TJ, Avula RT et al (2014) Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 85:677–685

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pooja Singh .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Singh, P., Francos, G., McCauley, J. (2018). Living Donor Evaluation and Selection. In: Ramirez, C., McCauley, J. (eds) Contemporary Kidney Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-19617-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19617-6_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19616-9

  • Online ISBN: 978-3-319-19617-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics